Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein

Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein

Item
http://www.wikidata.org/entity/Q34856100
Construction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactinEffects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal deliveryImmunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.Characterization of fluorescent chimeras of cholera toxin and Escherichia coli heat-labile enterotoxins produced by use of the twin arginine translocation systemIntradermal immunization of mice with cholera toxin B-pneumococcal surface protein A fusion protein is protective against intraperitoneal challenge with Streptococcus pneumoniae.Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization.Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A2/B chimera induces antigen-specific Th2-type responses in mice.Improved efficacy of a licensed acellular pertussis vaccine, reformulated in an adjuvant emulsion of liposomes in oil, in a murine model.Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in miceIntranasal vaccines for protection against respiratory and systemic bacterial infections.Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.Mucosal vaccination against bacterial respiratory infections.Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses.Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
P2860

Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein

Item
http://www.wikidata.org/entity/Q34856100
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@ast
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@en
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@nl
type
label
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@ast
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@en
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@nl
prefLabel
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@ast
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@en
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Mucosal immunization with a ge ...... xin subunit B chimeric protein
@en
P2093
P2860
P304
P31
P356
10.1128/IAI.71.4.2272-2275.2003
P407
P433
P478
P50
P577
P698
P921
P932